Skip to main content

Viaskin Peanut FDA Approval Status

FDA Approved: No
Brand name: Viaskin Peanut
Generic name: peanut immunotherapy
Company: DBV Technologies
Treatment for: Peanut Allergy

Viaskin Peanut is an immunotherapeutic skin patch in development for use in the treatment of peanut allergy.

Development timeline for Viaskin Peanut

DateArticle
Dec 19, 2018DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age - BLA Withdrawn
Nov 20, 2018DBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic Children
Oct 22, 2018DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer